We describe a cell damage-induced phenotype in mammary carcinoma cells involving acquisition of enhanced migratory and metastatic properties. Induction of this state by radiation required increased activity of the Ptgs2 gene product cyclooxygenase 2 (Cox2), secretion of its bioactive lipid product prostaglandin E2 (PGE2), and the activity of the PGE2 receptor EP4. Although largely transient, decaying to low levels in a few days to a week, this phenotype was cumulative with damage and levels of cell markers Sca-1 and ALDH1 increased with treatment dose. The Sca-1 + , metastatic phenotype was inhibited by both Cox2 inhibitors and PGE2 receptor antagonists, suggesting novel approaches to radiosensitization.
Introduction
Cancer cells that survive cytotoxic therapies such as radiation or genotoxic agents can become highly resistant to further treatment and develop an increased capacity for repopulation, invasion, and metastasis (Lee et al., 2017; Weng et al., 2013; Woodward et al., 2007) . The underlying mechanisms that lead to such treatment-induced tumorigenic properties are of clinical importance but not yet fully understood. Our studies showed that such cells expressed high levels of the surface marker Sca-1 (stem cell antigen-1, also known as Ly6A). Sca-1 is a mouse glycosylphosphatidylinositol-anchored surface protein (GPI-AP), initially used as a marker of hematopoietic stem cells (SC) (Bradfute et al., 2005; Holmes and Stanford, 2007) and more recently some populations of mammary tumor initiating cells (TIC) (Weng et al., 2012) . Sca-1 is regulated downstream of Wnt/beta-catenin signaling and is thought to play a functional role in mammary cancer tumor initiation and cells undergoing a cellular wound healing response, triggered by cell death and migration (Batts et al., 2011) . Mammary tumor cell populations responding to cytotoxic therapy (Lee et al., 2017; Weng et al., 2013; Woodward et al., 2007) may undergo dedifferentiation to a more resistant state in a fraction of the population. A similar phenomenon was termed the 'Phoenix Rising' response and was shown to be triggered through activation of caspases 3 and 7 induction of phospholipase A2 (Huang et al., 2011; Li et al., 2010) .
In this study, we have examined the properties of cells expressing high levels of Sca-1 after cytotoxic treatment and key mechanisms involved in increased tumor cell migration and metastasis. In previous studies, increased resistance to radiation and enhanced metastasis was found in a population of primary mouse mammary cells expressing cell surface Sca-1 (Holmes and Stanford, 2007; Weng et al., 2012 Weng et al., , 2013 . In this study, we showed that radiation induces cells (4T1, MMT) expressing high levels of Sca-1 which exhibit enhanced migratory and metastatic activities. The response required induction of cyclooxygenase 2 (Cox2) and its bioactive lipid product prostaglandin E2 (PGE2). This phenotype was however inhibited by both Cox2 inhibitors and PGE2 receptor antagonists, leading to profound inhibition of radiation-induced metastasis.
Results

Enrichment in subpopulations of mammary carcinoma cells expressing elevated surface levels of Sca-1 after cytotoxic treatment
Surface levels of Sca-1 were shown previously to be increased in radioresistant, invasive, and metastatic MMT mammary carcinoma cells in vitro and in vivo (Weng et al., 2013) . In this study, we used 4T1 murine mammary rather than MMT for most studies as MMT, being primary cells grew for only one to two generations in vitro. When 4T1 carcinoma cells were treated with gamma-irradiation in fractions of 6 Gy for up to three times, the population of cells positive for Sca-1 was found to increase with escalating dose (Fig. 1A, B ) and similar changes were observed using immunocytochemical (ICC) staining (Fig. 1C-F ). Irrespective of whether cells were irradiated daily or every second day, similar increases in the numbers of Sca-1positive cells were observed (Fig. 1C-F ). Although the degree to which Sca-1 increases differed in cells irradiated one, two or three times, the kinetics of expression and decay were similar, with significant increases observed on day 6, induction peaking on day 9 and Sca-1 levels thereafter declining (Fig. 1G ). On day 21, the Sca-1 levels had almost returned to the baseline in each case, although a small number of Sca-1 + cells were retained (Fig. 1G) . Interestingly, re-exposure of previously irradiated cells after decay in Sca-1 levels, regardless of whether once or three times pretreated, boosted the expression of Sca-1 ( Fig. 1H ). Cells thus seemed to have a prolonged molecular memory of previous irradiations in terms of re-induction of Sca-1. In addition to radiation treatment, Sca-1 + cells were also induced by the cytotoxic drugs doxorubicin and Fig. 1 . Genotoxic stress leads to enrichment of Sca-1 in the 4T1 cell line and in MMT mammary tumors. (A) 4T1 cells were irradiated with 6 Gy for up to three times. After IR, cell culture medium was replaced and cells were collected for FACS analysis with the indicated antibodies. (B) The mean percentage of CD44 and Sca-1 double-positive cells in three repeated experiments is shown AE SD. (C-F) 4T1 cells were irradiated every second day (C) or every day (E) and Sca-1 expression assessed by ICC staining, scale bar 20 lm. The mean percentage of Sca-1-positive (red-stained) cells is also shown AE SD (D and F). (G) Timeline of Sca-1 induction in 4T1 cells irradiated with 6 Gy for one, two, or three times. The cells were collected at the indicated times, stained with Sca-1 mAb, and analyzed by FACS. (H) Cells treated as in G were irradiated again with 6 Gy twice on day 30 and 32 when Sca-1 levels had returned to baseline, and then assayed for the re-expression of Sca-1 after overnight culture. The P values were obtained by re-irradiated cell to non-re-irradiated cells previously irradiated one, two, or three times. (I) MMT tumor cells were transplanted into wild-type C57BL/6 mammary fat pad as described in Experimental procedures. On day 10, established tumors were treated with 9 Gy radiotherapy. Sca-1 expression with tumor sections was assessed by IHC on days 3 and 5 after treatment, scale bar 20 lm. (J) Mean numbers of Sca-1 + cells in imaged IHC MMT tumor sections is shown AE SD. (K) 4T1 cells were stained with anti-CD44 and anti-Sca-1 mAbs, and then, Sca-1 À population was selected by cell sorting (left side). Sca-1 À 4T1 tumor cells were then separated into a nonirradiated sample and an irradiated 6 Gy 9 2 every other day sample. After ON culture, the cells were stained with anti-Sca-1 and-CD44 mAbs and analyzed by FACS and ICC, scale bar 20 lm. (L) The Sca-1 À population of 4T1 cells were irradiated with 6 Gy once, twice or three times, and then analyzed by FACS. Nonirradiated cells were used as controls. The percentage of Sca-1 + cells is presented in the bar graph. cisplatin, indicating a general response to genotoxic stress ( Fig. S1 ). When we examined the effects of tumor irradiation in vivo, we observed a similar phenomenon, with cells staining positive for Sca-1 ( Fig. 1I ). Significant increases in Sca-1 + cells were observed within tumor sections on day 3, increasing to day 5 ( Fig. 1I, J) .
We next tested the possibility that enrichment of Sca-1 + cells was due to preferential killing of radiation-sensitive Sca-1 À cells. To determine the origin of Sca-1 + cells, 4T1 mammary carcinoma cells were sorted to select the Sca-1 À cells (Fig. 1K ), and the Sca-1 À cells were then exposed to radiation. Even though these populations were selected to exclude Sca-1 + cells, radiation still led to the expression of Sca-1, with up to 33% of these cells becoming Sca-1 + after three 6 Gy radiation exposures ( Fig. 1K , L). To examine whether the observed enrichment of Sca-1 + cells was due to divergent rates of radiation-induced cell death between Sca-1 + and Sca-1 À cells, we examined cell viability within each of these populations after treatment. Unlike lymphoid-derived cancer cells that readily undergo apoptosis after irradiation the fate of most irradiated tumor cells of epithelial origin is senescence, necrosis, or a slow form of death termed mitotic catastrophe. These latter fates of epithelial tumor cells are alternative outcomes to apoptosis, which is largely inaccessible to many types of cancer due to frequent genetic disruptions in the apoptotic pathway. Thus, in most tumor types of epithelial origin, apoptosis is rare. At the dosages used in this study, our analysis showed no statistical difference in cell viability between irradiated and nonirradiated cells within 24 h after irradiation ( Fig. S2A ). In addition, no statistical difference in cell viability was observed between Sca-1 + and Sca-1 À cells within irradiated samples ( Fig. S2B ). Together, these data indicate irradiation strongly induces Sca-1 expression by a mechanism that does not involve selective cell death of Sca-1 À cells.
Irradiation induces Sca-1-expressing cells with enhanced migratory and metastatic ability
Our previous experiments had shown the Sca-1 + MMT mammary tumor cells to have enhanced migratory and metastatic properties (Weng et al., 2012) . This was true both for the fraction of such cells present in untreated MMT mouse mammary cell populations in vivo that mediate cell renewal and the radiation-induced Sca-1 + fraction (Weng et al., 2013; Weng et al., 2012) . To further determine the properties of the Sca-1 + cells in 4T1 cells, they were exposed to ionizing radiation then assayed for migratory ability, using a double-chamber method. Irradiation markedly increased the cell number capable of penetrating the filter ( Fig. 2A, B ). To determine the phenotype of the cells passing through the filter, Sca-1 + and Sca-1 À 4T1 cells were selected by cell sorting, and then twice irradiated with 6 Gy and subjected to cell migration assay. Consistent with the findings in Fig. 2A , B, no cells in the Sca-1 À population passed through the filter if nonirradiated. In contrast, many cells in both irradiated Sca-1 À and Sca-1 + populations migrated through the filter (Fig. 2C, D) . Moreover, cells that migrated through the filter were Sca-1 + whether from either sorted Sca-1 À or Sca-1 + populations (Fig. 2C, D) . The absolute numbers of cells passing through the filter in the irradiated Sca-1 + cells were more than those in the irradiated Sca-1 À cells (Fig. 2C, D) . These results indicate Sca-1 + cells, regardless of their origin from Sca-1 + or Sca-1 À cell populations, possess enhanced migratory ability. We next examined the effects of radiation on MMT tumor metastasis in vivo. We chose this mouse mammary tumor model as MMT cells have been engineered to express GFP and can thus be positively identified and distinguished from normal cells in metastatic tissues. ICC staining of sections of primary MMT tumors growing in the mammary fat pads had shown marked enrichment for Sca-1 after radiation treatment ( Fig. 1I ). Analysis of the draining lymph nodes from the same animals indicated marked increases in Sca-1-stained cells ( Fig. 2E, F) . These findings therefore suggested increased metastasis of the Sca-1 + cells after radiotherapy. Metastasis from the primary site was confirmed by detection of GFPexpressing tumor cells in the lymph nodes after irradiation of the primary site that also stained positive for Sca-1 ( Fig. 2G ).
Changes in gene expression after radiotherapy
To further define the phenotypes of Sca-1 + cells produced in response to radiation treatment, we next examined the relative expression of a subset of mRNAs in irradiated tumor cells using a qPCR array specific for TIC-associated genes (Fig. S3A ). The mRNA species that were up-or downregulated in 4T1 cells in response to radiation are therefore shown in and assayed for cell migration using a two-chamber method. Irradiated or control 4T1 cells were placed in triplets on the filter of upper side of a migration chamber and cultured. At the indicated times, the filters were gently removed and the cells on the upper side of filter were cleared. The cells in the lower side of filter were fixed with 4% paraformaldehyde and stained with 0.5% crystal violet. Filters were then photographed with representative fields shown, scale bar 50 lm. (B) Mean number of migrated cells per field under 109 magnification is shown AE SD. The P values were obtained by comparing the mean number of migrated cells between nonirradiated cells (0 Gy) and irradiated cells. (C and D) 4T1 cells were sorted into Sca-1 (À) or Sca-1 (+) cells that were then treated with twice 6 Gy every other day. The migration ability of these cells was measured by a two-chamber method. After 6 h of culture, the cells migrated to the other side of the filter were stained with 0.5% Crystal violet or anti-Sca-1 antibody, scale bar 50 lm. The cells were counted and mean cells per field is presented in the bar graph for each condition AE SD. (E) Sca-1 expression was assessed by IHC staining of draining lymph node sections of nonirradiated MMT tumors and tumors 3 and 5 days after 9 Gy irradiation, scale bar 20 lm. (F) The percentage of Sca-1-positive cells in draining lymph nodes is represented AE SD. (G) GFP-MMT tumor cells within the draining lymph nodes of wild-type C57BL/6 mice could be detected by GFP expression and were positive for Sca-1.
c-Kit (Visvader and Stingl, 2014) , and ABCG2, a protein involved in SC chemoresistence (An and Ongkeko, 2009 ). Real-time RT-qPCR confirmed large increases in Sca-1 and Aldh1a1 mRNA ( Fig. S3B ). Of note, Ald-h1a1 was upregulated 10-to 12-fold compared with levels in control cells (Fig. S3 ). These data were also confirmed by the finding that ALDH enzymatic activity was significantly increased in the irradiated murine 4T1 (Fig. S4A, B ) and human MCF7 mammary carcinoma cells (Fig. S4C, D) . In addition, the ALDHenriched 4T1 population also had a Sca-1 + phenotype as determined using a triple staining/flow cytometry approach (Fig. S4E ). Exposure to radiation thus led to a profound increase in the subpopulation of cells with elevated levels of surface Sca-1 and intracellular ALDH1.
2.4. The Sca-1 + /ALDH1 + /migratory phenotype was induced using medium conditioned by irradiated cancer cells
As secreted products can mediate radiation resistance, we next asked whether induction of the Sca-1 + CD44 + ALDH1 + migratory phenotype could similarly be caused by factor(s) released from irradiated cells (Brocard et al., 2015; Dent et al., 2003) . Tissue culture medium conditioned by irradiated cells was indeed able to cause formation of a large population of Sca-1 + 4T1 cells when added to previously untreated cultures (Fig. 3A, B ). Unlike Sca-1 + cells in irradiated cultures, most of which had an abnormal cellular morphology and multiple and/or giant nuclei (see Fig. 1C , E), cells treated with radiation-conditioned medium maintained similar nuclear morphology and size to controls (Fig. 3C ). In addition, cells cultured in radiation-conditioned medium acquired enhanced migratory properties proportionate to the dosage of radiation applied to cells from which the medium was taken (Fig. 3E, F) . Therefore, bioactive substance(s) appear to be released from irradiated cells mediating the induction of the Sca-1 + /migratory phenotype. One secreted product that has been associated with responses to tissue damage is PGE2 (Li et al., 2010) . Therefore, we considered the potential role of Cox2 a key enzyme required for PGE2 synthesis in the phenotype. Radiation injury of 4T1 cells led to increased Cox2 mRNA ( Fig. 3G ) and protein expression ( Fig. 3I ). In addition, the levels of PGE2 detected in the medium of irradiated 4T1 cells were increased in a dose-dependent manner (Fig. 3H ). Doxorubicin treatment also induced amplification of Cox2 at the protein level and PGE2 production ( Fig. 3J, K) . Thus, PGE2 is released abundantly from irradiated or doxorubicin-treated cells and could be one mediator of the cell damage-induced Sca-1 + /migratory phenotype.
Suppression of radiotherapy-induced Sca-1 + by pretreatment with Cox2 inhibitors
To assess the role of Cox2 in the radiation-induced Sca-1 + phenotype, we used the specific Cox2 inhibitor celecoxib (McCormack, 2011) . 4T1 tumor cells were pretreated with celecoxib and irradiated with 6 Gy for up to three times. Co-treatment with celecoxib was effective in blocking induction of Sca-1 + by radiation ( Fig. 4A, B) . Similar results were obtained in cells pretreated with ibuprofen, a nonsteroidal inhibitor of both Cox1 and Cox2 (Davies, 1998) (Fig. 4A, B ). Pretreatment with 50 lM of celecoxib or 100 lM ibuprofen reduced the Sca-1 + cell numbers almost to background levels in radiation-treated cells (Fig. 4C, D) . Similarly, pretreatment with celecoxib or ibuprofen led to a reduction in the cell population with ALDH activity measured by ALDEFLUOR TM assay (Fig. 4E , F). The Sca-1 + fraction of irradiated cells was closely associated with an enhanced migratory and metastatic phenotype (Fig. 2 ) an effect that was almost completely inhibited by 50 lM celecoxib or 100 lM ibuprofen ( Fig. 3G, H) . These data provided further evidence supporting the requirement for elevated levels of cellular Cox2 and extracellular PGE2 in the genotoxic treatment-induced migratory, Sca-1 + cell phenotype. As the cells appeared to be undergoing some level of dedifferentiation after radiation, we also examined tumorsphere formation, an index of tumor stem cell or progenitor properties. Radiation increased tumorsphere formation and this effect was partly inhibited by Cox2 inhibitors or antagonist of the PGE2 receptor EP4 (Fig. 4I, J) .
2.6. The PGE2 receptor EP4 supports the genotoxic stress-induced Sca-1 + phenotype
We next asked whether the PGE2 receptor EP4 on the 4T1 cell surface was involved in the induction of Sca-1 + CD44 + (Fig. 5 ). Although cells can potentially express at least four PGE2 receptor subtypes (EP1-4), EP4 seems particularly significant in mammary cancer metastasis (Kundu et al., 2009; Ma et al., 2006; Reader et al., 2011) . Blocking EP4 with its specific antagonist L161,982 led to a drug dose-dependent reduction in the formation of radiation-induced Sca-1 + cells (Fig. 5A, B) . The EP4 inhibitor also suppressed the effects of radiation-conditioned medium on upregulation of Sca-1 + CD44 + in 4T1 cells (Fig. 5C , Cells passing through filter Fig. 3 . Medium conditioned by cells exposed to genotoxic agents induces elevated Sca-1 levels and increased migration in nonirradiated cells. 4T1 cells were cultured with medium derived from 4T1 cells irradiated with 6 Gy one, two, or three times. The radiation-conditioned medium (med) was changed every other day. (A) 4T1 cells cultured with medium derived from irradiated cells were stained with the indicated mAbs and analyzed by FACS. (C) Cells treated as in A were visualized with anti-Sca-1 antibodies, using ICC staining, scale bar 20 lm. The mean percentages of Sca-1-positive cells in three experiments are shown AE SD (B, D). Cell migration assays were next carried out on cells exposed to conditioned medium, using a two-chamber method (E, F). Cells treated as in A and C were placed in triplet wells on the upper side of the filter and incubated for 12 h. The cells in the lower side of the chamber were then stained and counted, scale bar 50 lm (E). Representation of mean across three replicate experiments is shown AE SD; P values were obtained by comparing cells cultured with medium from nonirradiated cells with those obtained from one, two, or three times irradiated cells (F). (G) Ptgs2 mRNA expression 24 h post-IR measured by real-time qPCR normalized to Tbp. Expression is represented as ratio to nonirradiated sample. P value estimated by one-way t-test of compiled fold change values to control. Figure shows representative mean of at least three independent experiments AE SD. (H) PGE2 levels in medium from irradiated or nonirradiated cells. Medium was collected at days 2-6 (D1-6) and quantified for PGE2 levels by ELISA. Compiled mean 6 Gy/0 Gy PGE2 ratios from at least three independent experiments are represented AE SEM. (I) Cox2 protein expression analysis by western blot 24 h after a second 6 Gy irradiation. Densitometry-quantified Cox2 levels were normalized to actin expression and shown as the mean of three independent experiments AE SD. (J) Western blot analysis of Cox2 protein levels after 100 nM doxorubicin for 48 h. Densitometry-quantified Cox2 levels were normalized to actin expression and shown as the mean of three independent experiments AE SD. (K) 4T1 cells were treated with 100 nM doxorubicin for 48 h; growth media were then replaced, and PGE2 levels in the culture media were assayed by ELISA following 6 h of further culture. Mean fold difference in PGE2 levels is shown across three replicate wells for each condition normalized to cell number within respective well AE SD. D). Celecoxib and L161,982 also prevented the increases in the Sca-1 + population induced by doxorubicin treatment (Fig. 4E, F) . The cumulative results from these studies (Figs 1-5 ) therefore suggested a cell damage-induced programming pathway for this Sca-1 + /metastatic phenotype with steps including: Tumor cell injury > Cox2 > PGE2 > PGE2-R > metastatic Sca-1 + cells.
Effectiveness of Cox2 inhibitors and EP4 antagonists in reducing radiation-induced tumor metastasis
We next examined the role of Cox2 and PGE2 in the induction of Sca-1 expression and tumor metastasis in vivo in the MMT mouse tumor model ( Fig. 5G, H) . MMT cells were pretreated with celecoxib (50 lM) or L161,982 (10 lM) overnight, and then, 10 6 of such cells were inoculated into cleared mammary fat pads. As before, radiation led to increases in Sca-1 + cells in tumors and lymph node metastases ( Fig. 5G, H , left panels). However, these effects of tumor irradiation were potently inhibited by the Cox2 inhibitor celecoxib and the EP4 antagonist L161,982 (Fig. 5G, H , middle and right panels).
Discussion
Our data therefore pointed to a mechanism of dosedependent, cytotoxic treatment-induced induction of mammary carcinoma cells with enhanced migratory, metastatic, and treatment resistant properties (Figs 1  and 2, Fig. S1 ). Cells and tumors treated with cytotoxic therapies exhibited a large increase in surface Sca-1 + , enhanced migration in vitro, and increased metastasis. Increases in Sca-1 levels and migratory potential also correlated with ALDH activity in 4T1 cells, and equivalent radiation treatments also induced ALDH activity in human MCF7 breast cancer cells (Fig. S4 ). The cluster of properties observed in the Sca-1 + ALDH1 + cells are sometimes observed in cancer stem cells (CSC) (Marcato et al., 2011) , and populations sorted for this CSC phenotype typically possess highly invasive and metastatic properties (Weng et al., 2012) . However, although irradiated cells showed some increases in properties ascribed to CSC (Sca-1 induction, ALDH expression, tumorsphere formation), it is not clear to what degree the cells correspond to known populations of normal mammary SC. It may be that cell populations exposed to the cytotoxic treatments respond in a homeostatic manner by acquiring some stem-like properties through dedifferentiation of progenitor or differentiated mammary tumor cells. The two genes observed to be most upregulated in irradiated 4T1 cells were ALDH1 and Sca-1 itself (Fig. S3 ). In addition to being stem cell markers, ALDH family proteins play functional roles, protecting stem cells from cytotoxic agents (Ma and Allan, 2011; Tomita et al., 2016) . Sca-1 is a surface GPI-AP, localizing to lipid rafts in cancer cells, and may play a key role in regulating cell migration through signaling mechanisms including modulation of Src family kinase activity (Batts et al., 2011; Holmes and Stanford, 2007) . It has also been suggested that a Sca-1 ligand may exist (Holmes and Stanford, 2007) , and it would be tempting to speculate that such a ligand could contribute to the effects of radiation-conditioned medium on cell migration. Irradiated cells also underwent a large increase in c-kit mRNA (Fig. S3) , an important factor in hematopoietic stem cell expansion (O'Laughlin-Bunner et al., 2001) . Thus, further expression profiling of the Sca-1-rich fraction of irradiated cells would be desirable to expand our understanding of mechanism.
The finding that exposure to conditioned medium from irradiated cells could induce Sca-1 surface expression and increase cell migration in cells indicates that products secreted into the medium were mainly responsible for inducing this phenotype. Consistent with past reports, we found increased Cox2 activity and PGE2 production to be important factors for the Sca-1 + phenotype, further underlining the importance of PGE2 in cell damage-induced regenerative responses (Allen et al., 2015; Huang et al., 2011) . PGE2 is thought to be involved in triggering the Wnt-beta-catenin pathway known to be activated by irradiation and leading to radiation-induced stemness (Goessling et al., 2009; Woodward et al., 2007) . In addition, Cox2 expression and PGE2 release have been shown to be dependent on activation of the transcription factor NFkB (Nakao et al., 2002) , which itself is induced by ionizing radiation (Dent et al., 2003; Huang et al., 2011; Wang et al., 1996) . The findings that radiationinduced mammary tumor metastasis could be reduced both by Cox2 inhibitors and EP4 antagonists in tumor bearing mice may be highly significant (Fig. 5G, H) . Inclusion of such agents in fractionated radiotherapy protocols could thus be desirable.
In summary therefore, our studies have indicated the inherent plasticity of mammary cancer cells and their ability to respond to genotoxic stress through the transient induction of cells with enhanced migratory and metastatic properties. These findings have discernable implications for fractionated radiotherapy if such resistant and metastatic cells were to accumulate progressively in the cancers of human patients with each dose. However, the changes we observed here appeared in other studies to be triggered in tandem with radiation-induced activation of tumor immunogenicity and specific cell killing by cytotoxic T cells (Formenti and Demaria, 2012; Surace et al., 2015) . Competition between the pro-metastatic and immunogenic effects of radiation may therefore mold overall responses to treatment. Our demonstration that radiation-induced migration and metastasis could be induced by secreted factors suggests that these may encompass a series of accessible therapeutic targets, of which targeting secreted eicosanoid products have been exemplified herein.
Experimental procedures
4.1. Cell maintenance, irradiation, and inhibitors 4T1 and MCF7 cells were purchased from The American Type Culture Collection and cultured in Dulbecco's modified of Eagle's medium (DMEM) with 10% heatinactivated fetal calf serum, 2 mM L-glutamine, and 100 lgÁmL À1 of both penicillin and streptomycin (Cellgro, Mediatech, Tewksbury, MA, USA) in a Heracell CO 2 incubator at 37°C and 5% CO 2 . For irradiation treatment, cells were plated in 100-mm tissue culture plates overnight and irradiated at the required doses with a Cesium 137 source at a dose rate of 1.06 GyÁmin À1 or 2.29 GyÁmin À1 . Cisplatin was purchased from Cayman Chemical Company (Ann Arbor, MI, USA) (L161,982), and ibuprofen, doxorubicin, and celecoxib were from Sigma, Franklin, MA, USA. MMT mammary tumor cells were from mice doubly transgenic for human mucin 1 Ag and polyomavirus middle T (PyMT) oncogene (Xia et al., 2003) . MMT mice were a kind gift from Sandra J. Gendler, Mayo Clinic, Scottsdale, AZ. Such MMT mice carrying the PyMT oncogene driven by the mouse mammary tumor virus long terminal repeat developed mammary carcinoma at a 100% incidence (Guy et al., 1992) .
FACS and immunocytochemical (ICC) staining
Cells were lifted with Accutase (ThermoFisher Scientific, Franklin, MA, USA) and washed in phosphate-buffered saline pH7.4 and then stained with Fixable Viability Dye eFluor 450 and antibody against Sca-1 (eBioscience, Franklin, MA, USA). For indicated experiments, cells were further stained with anti-CD44 mAb (eBioscience) using standard immunofluorescence staining method. The Sca-1 single-or Sca-1 + CD44 + double-positive cells were quantified by FACS (Gallios, Beckman Coulter, Pasadena, CA, USA) and analyzed with FlowJo or FACScan. Dead cells were omitted from marker quantification based upon viability dye staining. To examine Sca-1 expression by ICC, cells (1 9 10 4 per plate) were cultured in small culture plates for indicated days after radiation treatment, cytocentrifuged onto the slide, and then stained with anti-Sca-1 antibody by standard ICC staining method and examined under light microscope. For Fig. S1A , cells were cultured on coverslips, fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton-9100. Cells were then stained with Sca-1 antibody and mounted using ProLong Gold Antifade Mountant with DAPI (ThermoFisher Scientific).
Cell migration assays
Multiwell cell migration assays were performed following established protocol (Kouspou and Price, 2011) . Multiwell chambers were incubated for the indicated time upon which cells on the upper side of filter were removed and those underside were then fixed and stained with 0.5% crystal violet staining or Sca-1 antibodies. Cells were counted using 409 magnification.
Western blotting
Cell lysates were collected in RIPA buffer (Boston BioProducts, Ashland, MA, USA) containing Halt TM Protease and Phosphatase Inhibitor Cocktail (Thermo Scientific, Orlando, FL, USA). Protein content of samples was derived using Pierce TM BCA Protein Assay Kit (Thermo Scientific). Equal protein from cell lysates wase subjected to SDS/PAGE followed by established western blot procedure (Chou et al., 2015) . Primary and secondary antibodies listed in Supporting information. The Ag/Ab signals were quantified with ECL reagent (GE) and autoradiography film (HyBlot CL, Denville Scientific, Holliston, MA, USA) or LI-COR Odyssey (Lincoln, MA, USA). Immobilon-FL and Immobilon-P poly(vinylidene difluoride) membranes (Merck Millipore, Burlington, MA, USA) were used for near-infrared (Odyssey) and HRP (HyBlot CL) detection methods, respectively. Densitometry of the membranes was performed using Image Studio Lite (LI-COR Biosciences). IMAGEJ was used to adjust contrast of western blot figure images without disturbing the relative ratio of signal.
RT-qPCR
Total RNA was harvested 24 h following the indicated treatment using RNeasy Mini Kit (Qiagen, Hilden, Germany) and converted to cDNA with iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA). Quantitative PCR amplification of 10 ng cDNA was performed using SYBR Green PCR Master Mix and 7300 Real Time PCR System (Thermo Fisher Scientific, Asheville, NC, USA) with cycle conditions: 50°C 2 min, 95°C 10 min, [95°C 15 s, 60°C 1 min] 9 40 cycles. Dissociation curve analysis confirmed single PCR products. Amplicon amplification efficiency and C t values were determined using the LINREGPCR software (Ruijter et al., 2009) . Amplicon primer sequences are provided in the Supporting information with corresponding PrimerBank ID where appropriate (Wang, 2003) .
PGE2 quantification by ELISA
Samples of radiation-treated cell-conditioned media and control media were collected and frozen at À80°C until analysis. Media samples from doxorubicin-treated cells were collected by replacing media on cells treated with doxorubicin for 48 h with agent-free growth media and culturing cells for a further 6 h at which time the media were collected and stored at À80°C. Cells were lifted and counted for normalization of PGE2 to sample cell number. Prior to ELISA assay, the cultured media samples were thawed on ice and clarified by centrifugation at 15 000 g for 15 0 at 4°C. PGE2 levels were quantified using Prostaglandin E2 ELISA Kit -Monoclonal (Cayman, Ann Arbor, MI, USA) as per the manufacturer's protocol.
Tumorsphere assay
Tumorsphere procedure was performed using methods previously published (Chang et al., 2012; Grange et al., 2008; Kim et al., 2010; Lee et al., 2015) . 4T1 cells were treated as indicated, 24 h after second irradiation, cells were lifted using trypsin or accutase and strained through a 40-lm cell strainer (USA Scientific, Orlando, FL, USA) and plated in 24-well ultra-low attachment plates (Sigma-Aldrich, Natick, MA, USA) at 8-10 cellsÁlL À1 in tumorsphere culture medium. Tumorsphere culture medium consisted of DMEM/ F12 medium with HEPES buffer, 10 ngÁmL À1 epidermal growth factor, 10 ngÁmL À1 basic fibroblast growth factor (Thermo Fisher Scientific), 4 lgÁmL À1 heparin, 0.5% methylcellulose, 5 lgÁmL À1 insulin (Sigma-Aldrich, Natick, MA, USA), 0.4% bovine serum albumin (Thermo Fisher Scientific, Asheville, NC, USA), and 1 lM hydrocortisone (Stem Cell Technologies, Vancouver, BC, Canada). Tumorspheres were incubated at 37°C and 5% CO 2 for 7 days at which time they were imaged and counted using a Celigo High Throughput Micro-Well Image Cytometer (Nexcelom Bioscience, Lawrence, MA, USA). Tumorsphere counts were performed using the Celigo tumorsphere mask analysis setting with parameters selected such that the minimum tumorsphere diameter was over 100 lm. General settings: analysis resolution, 4 lm per pixel; well mask, 96%; well mask usage automatic. Identification settings: colony diameter, 400 lm; precision, low; border dilation, 0; minimum thickness 0; background correction, yes. Prefiltering settings: area, 1 9 10 4 to 2 9 10 6 lm; intensity range, 0 to 255; min. aspect ratio, 0.05.
Assessment of ALDH activity
Cells at 1 9 10 4 cellsÁmL À1 were seeded in 100-mm cell culture plates and irradiated with 6 Gy every second day up to three irradiations. The ALDH activity of the cells was assayed according by the ALDE-FLUOR TM assay according to the manufacturer's instructions (Stem Cell Technologies). Briefly, 10 6 cells were resuspended in 1 mL of aldefluor assay buffer with activated aldefluor substrate. As a negative control for each sample, an aliquot of 'aldefluor-exposed' cells were immediately quenched with a specific ALDH inhibitor, DEAB. Following a 45 0 incubation at 4°C, the cells were centrifuged. Cell pellets were resuspended in 0.5 mL aldefluor assay buffer and analyzed by FACS (Becton Dickinson, Franklin Lakes, NJ, USA). For triple staining, suspended single cells were stained with PE-conjugated Sca-1 and Cy-conjugated CD44 mAbs, and then stained for ALDH + cells as described above. The ALDH + Sca-1 + CD44 + cells were analyzed by flow cytometry.
Radiotherapy in vivo
GFP + MMT tumor cells (10 6 ) were inoculated into the right and left mammary fat pads of wild-type C57BL/6 mice. On day 10, the tumors (about 5 mm 3 ) in the right side received radiation at 9 Gy using XRAD320 (Precision X-Ray Inc., Branford, CT, USA). The mice were sacrificed on days 3 and 5 after radiation. Then sections of tumor or draining lymph node were prepared, stained with anti-Sca-1 antibodies, and examined by light microscopy. Mice were housed and handled in facilities accredited by the American Association for the Accreditation of Laboratory Animal Care. The study was carried out in accordance with the animal protocol approved by the Institutional Animal Care and Use Committee of Boston University Medical Center. The mice were sedated with intraperitoneal administration of ketamine (75 mgÁkg À1 ) and xylazine (5 mgÁkg À1 ), and then, the tumor was irradiated with 9 Gy by XRAD 320 (Precision X-Ray Inc., N. Branford, CT, USA). The XRAD320 is a self-contained X-ray system for delivering a precise radiation dosage to the tumor in small animals. Thus, the systemic exposure of radiation was avoided. The mice were closely followed and would be euthanized if they showed inactivity, ruffled fur coat, or anorexia.
Statistical analysis
Statistical significance was determined using Student's t-test or X 2 -test. One-way analysis of variance (ANOVA) was used for analysis of data with more than two subgroups and Tukey's post hoc test was used for further statistical inference between subgroups. P-values of < 0.05 were considered statistically significant. SPSS STATISTICS software (IBM, Armonk, NY, USA) and Microsoft Excel were used to attain these values.
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